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Abstract: Glomerular filtration (kidney clearance) of glucose occurs at high glucose concentrations. 
Thus, the applicability of glomerular filtration terms in models of insulin and glucose pharmaco-
dynamics (PD) should be investigated.  
To evaluate such a term, data from 36 insulin sensitivity tests on 12 participants with type 2 diabetes in 
an Atkins diet intervention study was analysed using three PD models. The models include the dynamic 
insulin sensitivity and secretion test (DISST) model the DISST model with an added glomerular filtration 
rate (GFR) term and the well-known Minimal Model (MM). The identified insulin sensitivity values and 
simulation fit-to-data residuals are analysed to test performance and differences. 
The Minimal Model produced the best fit-to-data with a median residual of 0mmol/L and IQR of -0.13, 
0.18mmol/L. Both DISST models also produced residuals with a median of 0mmol/L but an IQR of 
approximately -0.41, 0.37mmol/L. However, the DISST derived sensitivity values were considerably 
more in accordance with expected trends, showing the expected 20-50% increase in sensitivity for most 
subjects due to the intervention. In contrast, the Minimal Model repeated the variable trade-off issue 
previously recorded for this model with insulin resistant participants. The Minimal Model sensitivity 
values were effectively random, and did not capture observable changes in insulin sensitivity of glucose 
clearance. 
The addition of a GFR term had a positive impact on the identified insulin sensitivity by shifting some 
values more toward expected and observable behaviour. However, more data must be made available for 
an exhaustive investigation of the applicability of this term for this type of usage.  
Keywords: Physiological Modeling, pharmaco-kinetics/dynamics, parameter identification, glomerular 
filtration, insulin sensitivity. 
 
1. INTRODUCTION 
The dynamic insulin sensitivity and secretion test (DISST) 
model was developed to define the insulin and glucose 
pharmaco- kinetics (PK) and -dynamics (PD) during a 
relatively low-dose, short-duration insulin-modified intra-
venous glucose tolerance test (IM-IVGTT) (Chase et al. 
2006, Lotz 2007, Lotz et al. 2008, Lotz et al. 2010). In 
contrast to the Minimal Model of insulin and glucose PK-PD 
(Bergman et al. 1979), the DISST model utilises a single 
metric (insulin sensitivity (SI)) to model glucose decay. 
Although the two-metric Minimal Model could potentially 
provide additional information about a test participant’s 
physiology, parameter interference and trade-off often occurs 
during identification as a result of assay error (Cobelli et al. 
1998, Pillonetto et al. 2002, Quon et al. 1994). Bayesian 
techniques or a modified model can partially mitigate this 
issue (Cobelli et al. 1999, Denti et al. 2009, Erichsen et al. 
2004, Pillonetto et al. 2003). 
This article compares the simple Minimal Model against the 
existing DISST model and a modified DISST model that 
includes a term for glomerular filtration (kidney clearance of 
glucose) which occurs at high glucose concentrations (Arleth 
et al. 2000, Rave et al. 2006). The added glomerular filtration 
term used here is derived from the model of (Arleth et al. 
2000). The models are presented in Equations (1)-(7): 
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Glomerular filtration DISST model: 
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The glomerular filtration model uses Equation (1) to model 
insulin PKs.  
Minimal Model: 
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where: equation nomenclature is defined in Table 1 
Sym’ Description Units 
Q Insulin concentration in the interstitium mU/L 
I Insulin concentration in the plasma mU/L 
nI 
Rate of insulin transfer between 
interstitium and plasma L/min 
nC Rate of insulin uptake to cells 1/min 
VQ 
Distribution volume of interstitial 
insulin L 
VG 
Distribution volume of glucose 
(variable) L 
G Glucose concentration mmol/L 
pG 
Glucose dependant rate of glucose 
clearance 1/min 
SIDISST 
Insulin sensitivity measured by the 
DISST model (variable) L/mU/min 
GFR Glomerular filtration rate mmol/L/min 
SIGFR 
Insulin sensitivity measured by the 
modified DISST model (variable) L/mU/min 
PX Glucose bolus or infusion mmol 
X Insulin action 1/min 
p1 Minimal Model rate variable  1/min,  
p2 Minimal Model rate variable 1/min, 
p3 Minimal Model rate variable L/mU/min2 
 SIMM 
Minimal Model insulin sensitivity 
(dependant on p2-p3) L/mU/min 
SGMM 
Glucose dependant rate of glucose 
clearance (dependant on p1) 1/min 
Table 1. Nomenclature from Equations (1)-(7) 
2. METHOD 
2.1 Study design 
An intervention investigation evaluated the effect of the 
Atkins diet in a cohort of overweight and insulin resistant  
individuals with established type 2 diabetes with a series of 
physiological measurements and insulin sensitivity tests. 
Baseline characteristics were obtained prior to the 
commencement of the diet. The Atkins diet was prescribed as 
per the “Atkins Diet Revolution” book over 12 weeks. Weeks 
12 to 24 involved a maintenance period during which time 
the goal was weight stability. Insulin sensitivity tests were 
undertaken at weeks 0, 12 and 24.  
This research was approved by the New Zealand Ministry of 
Health, central regional ethics committee. 
2.2 Participants 
Fourteen individuals were recruited from the Wellington 
region of New Zealand to take part in the study. Inclusion 
criteria required that subjects had established type 2 diabetes 
and were aged between 30 and 65 years with a BMI between 
27 and 40 kg/m2. Participants were excluded if they had any 
major physiological or psychological illness at the time of 
testing, or were pregnant or lactating. During the study two 
subjects were omitted from the investigation (with one citing 
personal problems and the other exacerbating a renal stone.) 
2.3 Test protocol 
The insulin sensitivity test used in this study was defined in 
(Ward et al. 2001), but is repeated here for clarity: 
A two-minute glucose infusion was began at t=0. The glucose 
infusion had a total glucose content of 0.2g/kg of participant 
bodyweight. An insulin infusion was started at t=2 minutes at 
a rate of 3.5mU/kg/min and was reduced to 0.5mU/kg/min at 
t=7 minutes. Further reductions occurred at t=17 minutes, to 
0.25mU/kg/min, and at t=50 minutes, to 0.1mU/kg/min. The 
infusion of 0.1mU/kg/min was maintained for the remainder 
of the test. This insulin profile was selected to mimic the first 
and second insulin production phases of healthy, normo-
glucose tolerant individuals. Blood samples were taken at  
times: t=-10, -5, -1, 0, 1, 2, 3, 4, 5, 6, 8, 10, 12.5, 15, 20, 25, 
30, 35, 40, 50, 60, 70, 80, 90, 100, 120, 140, 160, 180, 210, 
240, 270, 300 minutes, and assayed for insulin and glucose. 
2.4 Model identification methods 
All model variables were identified using the iterative 
integral method (Docherty et al. 2009, Hann et al. 2005), 
which is briefly described below for the DISST, with 
extensions for the GFR and Minimal Models. As the models 
tested all use single compartment representations of insulin-
glucose PDs, the data immediately after the glucose bolus 
will be discarded. The glucose concentrations in this period 
are an artefact of slow mixing, and although this can be 
modelled by two-compartment models, the resulting kinetic 
metrics are of little clinical relevance or value. Thus, this 
study will ignore glucose data between 0 and 10 minutes.  
  
     
 
2.4.1 DISST model identification: 
Initially, an approximation of the plasma insulin 
concentration is made by using a linear interpolation of the 
frequently-sampled plasma insulin data. This is used in 
Equation (1a) to simulate interstitial insulin. 
Equation (2) is integrated and separated into the coefficients 
of the variables: 
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Equation (8) is evaluated for each coefficient at each of the 
sample times except for the data between t=1 and 8 inclusive 
(n=-10, -5, -1, 0, 10, 12.5, …, 360) using a linear 
interpolation of the glucose data. This manipulation allows a 
matrix equation to be formulated: 
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SI and 1/VG are identified using linear least squares and G(t) 
is re-simulated using Equation (2) with these values. This 
enables an improved evaluation of the coefficients of 
Equation (8) and re-identification of SI and VG. The process 
of re-simulating G(t) and re-identifying SI and VG is iterated 5 
times, by which time variable convergence is generally on the 
order of 0.1%. 
2.4.2 DISST with glomerular filtration model identification 
The incorporation of GFR alters the DISST identification 
method very little. A GFR profile is evaluated for the 
duration of the test using the most recent glucose estimation 
and Equation (4). Initially, an interpolation of the glucose 
measurements is used, then the refined glucose concentration 
simulations are used. Equation (8) is thus modified as 
follows: 
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The coefficients of Equation (10) are used in Equation (9) to 
identify SI and VG and continue the iterative process as 
described in Section 2.4.1. 
2.4.3 Minimal Model identification 
The governing equations of the Minimal Model are 
rearranged to enable identification with the iterative integral 
method. Equation (5) can be rearranged and substituted into 
Equation (6) yielding: 
D  D  E 
 	   	 <  D   (11)   I
 	  	 E 
 	    < 
D  #$%
(12) 
Equation (12) can be integrated and evaluated for the 
coefficients of the variables at the sample times: O   	 Q9    	  Q?   G  D H Q^  	  G  
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Again, a matrix equation is evaluated for the variables: 
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The Minimal Model contrasts from the DISST model in that 
the form of the X(t) profile depends on the form of the G(t) 
profile and must be re-evaluated (with Equation 5a) at each 
iteration. As such, parameter stability is not assured, and care 
must be taken to ensure parameter convergence. To ensure 
convergence, the change allowed in the identified variables is 
limited to 20% per iteration. 
2.5 Evaluation methods 
The identified variables from the three models will be 
presented and their ability to measure the clinical outcomes 
of the trials will be evaluated over the cohort and for 
individual cases. Furthermore, the median and inter-quartile 
range (IQR) of the residuals will be presented. The residual 
calculations will not include data omitted by the 
identification methods. 
As the DISST model was designed for short duration tests, 
wherein counter-regulatory effects have minimal influence on 
the identified results, both the full data sets and an 
abbreviated version are used. The full data set uses data 
between t=-10 and t=360 minutes, while the shortened set 
will only use data between t=-10 and t=60 minutes. Both data 
sets exclude the glucose data between 1 and 8 minutes.  
3. RESULTS 
The models analysed produced the residuals shown in Figure 
1 and summarised in Table 2. Figure 2 shows the raw data 
and simulated glucose profiles from the three sensitivity tests 
from an indicative cohort subject (Subject 3). 
The abbreviated data set analysis produced the lowest 
residual error for each model tested. Thus, the insulin 
sensitivity values identified in this analysis are presented in 
Table 3 with basal glucose. The basal glucose allows an 
indication of the expected shift in insulin sensitivity. 
  
     
 
 
Figure 1. Residual plots from the three models using both full 
and abbreviated data sets. 
Table 2. Residuals of the simulated glucose profiles 
compared to the measured data [mmol/L].  
 
 
Figure 2. Raw data, simulated glucose profiles  and plasma 
insulin concentrations from the three insulin sensitivity tests 
of Subject 3. 
 
Basal Glucose [mmol/L] DISST DISST + GFR Minimal Model 
Subject test 1 test 2 test 3 test 1 test 2 test 3 test 1 test 2 test 3 test 1 test 2 test 3 
1 16.9 11.4 11.7 4.61 1.26 1.62 3.35 1.23 1.56 0.41 0 0 
2 6.7 6.0 5.9 3.77 4.35 5.31 3.77 4.35 5.31 0.16 0.33 0.34 
3 16.3 10.3 10.8 5.65 5.90 6.16 3.42 5.23 5.63 0.61 0 0.07 
4 7.7 6.6 6.7 5.46 7.77 11.46 5.46 7.77 11.46 6.67 3.33 0.00 
5 8.5 6.7 7.6 5.78 6.09 5.58 5.78 6.09 5.58 3.45 0.38 1.63 
6 7.5 7.1 6.7 2.30 3.07 3.13 2.30 3.07 3.13 0 10.92 0.02 
7 14.4 12.6 10.0 3.46 4.83 6.32 3.02 4.63 6.25 0.75 0.96 0 
8 6.6 6.5 6.8 13.64 15.01 12.36 13.64 15.01 12.36 14.10 9.86 18.27 
9 9.1 5.1 6.1 1.61 3.41 4.99 1.61 3.41 4.99 0 0.22 0.02 
10 6.6 5.6 9.9 3.59 8.09 2.98 3.59 8.09 2.92 0.05 13.53 1.41 
11 7.2 7.0 6.4 5.72 5.41 10.10 5.72 5.41 10.10 0.34 2.58 0.06 
12 8.6 6.6 7.2 3.44 7.97 5.15 3.44 7.97 5.15 0.32 17.41 4.44 
Table 3. Basal glucose and insulin sensitivity values identified using test data between t=-10 and 60 minutes [L/mU/min]. 
4. DISCUSSION 
The residuals shown in Figure 1 and Table 2 show that the 
Minimal-Model enabled greater adherence to the measured 
data than the DISST models. This is an artefact of the 
contrasting modelling approaches. The Minimal Model uses 
four variables to model glucose that are known to trade-off 
during identification (Caumo et al. 1996, Pillonetto et al. 
2002, Quon et al. 1994). Thus, the accuracy of the 
physiological variables is reduced for the benefit of improved 
data-fitting. In contrast, the DISST model uses two variables 
that produce poorer residuals, but yield more stable and 
relevant diagnostic clinical metrics. 
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Model Median (IQR) Median (IQR) Median(IQR) 
DISST 0 (-0.412, 0.385) 
0 
(-0.115, 0.149) 
0.075 
(-0.102, 0.500) 
GFR 0 (-0.415, 0.368) 
0 
(-0.112, 0.146) 
0.077 
(-0.095, 0.511) 
MM 0 (-0.130, 0.180) 
0 
(-0.100, 0.122) 
0 
(-0.188, 0.226) 
  
     
 
Insulin sensitivity values from the models further confirmed 
this contrast in modelling strategies. The Minimal Model 
encountered the same parameter estimation issues published 
previously, and showed very poor continuity in sensitivity 
between trials for the study subjects. It is clear that variable 
trade-off occurred in this cohort for whom the Minimal 
Model has known problems  (Quon et al. 1994).  
In particular, the results of Subject 3 (Figure 3) highlight the 
different behaviours of the three models. Although there is 
very little shift in the insulin profiles across the three tests, 
there is an improvement in the rate of glucose decay. 
Furthermore, the basal glucose concentration was reduced 
considerably after the first test, indicating a significant 
improvement in this participants physiology. Although the 
standard DISST model captured an improvement, it was not 
of the magnitude expected. However, the addition of the GFR 
term produced more expected values. The Minimal Model 
insulin sensitivity values did not identify the expected trend, 
and it is obvious that parameter trade-off occurred during 
identification. 
In contrast, the DISST models showed the expected increase 
in insulin sensitivity for most of the participating subjects. 
The exceptions were Subject 1 who had a drastically 
improved basal glucose; Subject 8 who maintained a 
relatively high sensitivity throughout the study; and Subject 
10 who misinterpreted the Atkins diet to allow deep-fried 
fish-and-chips, and the resultant insulin sensitivity value was 
somewhat expected! 
The addition of the glomerular filtration term seems to be a 
sensible addition to the model. The term only affects the 
sensitivity values of subjects who have high fasting glucose 
concentrations. For example, the standard DISST model 
seems to have over-estimated the Trial 1 insulin sensitivity of 
Subject 1. Within this cohort, the term had a significant effect 
on the sensitivity values of Subjects 1, 3, and 7. The added 
GFR term seems to have shifted the sensitivity values in the 
expected direction in each case.  
The available data is not sufficient for an exhaustive analysis 
of the applicability of the GFR term for this type of test. 
However, this analysis has shown that the un-expected 
insulin sensitivity values from some participants with 
elevated fasting glucose were shifted further toward expected 
behaviour with the incorporation of the GFR term.  
The residuals shown in Figure 1 indicate that all of the 
models tested were not particularly suited to defining the 
PK/PDs of these individuals during the protocol used. The 
protocol included an insulin infusion designed to mimic that 
of healthy normo-glucose tolerant individuals. The infusion 
contained first phase, second phase and continuous infusions. 
In many cases, the continuous infusion reduced the subjects’ 
glucose below their basal concentrations. Thus, the SGMM and 
PG terms would become positive, denoting increased glucose 
production, (both model terms drive glucose back toward 
basal concentrations). In reality, it seems as though the 
exogenous insulin infusion was allowing the subjects 
physiology to drive the glucose concentration toward a 
healthy range. It could be supposed that this contrast between 
‘basal’ and ‘set-point’ glucose concentration for these insulin 
resistant subjects was the cause of the poor residual results of 
the DISST models and the variable trade-off presented by the 
Minimal Model.  
This analysis has chosen to analyse the simple Minimal 
Model in the form it was presented by (Bergman et al. 1979). 
It is well known that there have been advances in the 
application of the Minimal Model, which include two-
compartment glucose (Cobelli et al. 1998, Mari et al. 2003), 
and Bayesian techniques to ameliorate variable trade-off 
(Denti et al. 2009, Pillonetto et al. 2002). The two-
compartment method was not used as the DISST model 
ignores the data immediately after the glucose bolus. (The 
assumption is that there is no relevant diagnostic information 
contained in this data.) Therefore, to allow a fair comparison, 
the single compartment Minimal Model is used. The 
Bayesian techniques reduce variable trade off, but ‘borrow’ 
information from isolated data sets. Thus, the resultant 
variable values are affected by the population results, and do 
not present a most accurate possible model simulation of the 
available data. 
5. CONCLUSIONS 
Predominantly, this analysis has shown that clinically 
relevant diagnoses are not necessarily achievable through 
accurate residuals, but through useful metrics and the 
avoidance of including too many variables in a model. 
Although the Minimal Model residuals were considerably 
better than those of the DISST models, the resultant insulin 
sensitivity values of the Minimal Model were quite different 
from the expected behaviour. In contrast, both DISST models 
generally produced insulin sensitivity values in accordance 
with expected trends.  
The added glomerular filtration term shifted some of the 
insulin sensitivity values of some subjects, and produced 
what would seem more reasonable outcomes. Although these 
findings are promising, more data must be made available for 
an exhaustive analysis of the applicability of the added term. 
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